Literature DB >> 18713823

Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin.

Nuria García de la Torre1, Miguel A Rubio, Elena Bordiú, Lucio Cabrerizo, Eugenio Aparicio, Carmen Hernández, Andrés Sánchez-Pernaute, Luis Díez-Valladares, Antonio J Torres, Montserrat Puente, Aniceto L Charro.   

Abstract

BACKGROUND: Adipocytes regulate blood vessel formation, and in turn endothelial cells promote preadipocyte differentiation through the expression of proangiogenic factors, such as vascular endothelial growth factor (VEGF)-A. Some adipocytokines and hormones also have an effect on vascular development.
OBJECTIVES: Our objectives were to analyze the relationship between weight and circulating VEGF-A in morbidly obese subjects before and after bariatric surgery, and investigate the relationship between circulating VEGF-A and certain adipocytokines and hormones regulating adipocytes.
METHODS: A total of 45 morbidly obese women and nine lean females were included in the study. Patients underwent bariatric surgery: vertical banded gastroplasty (n=17), gastric bypass (n=17), and biliopancreatic diversion (n=11). Serum samples for VEGF-A, adiponectin, leptin, ghrelin, and insulin were obtained preoperatively and 9-12 months after surgery.
RESULTS: Obese patients showed significantly higher VEGF-A levels than controls (306.3+/-170.3 vs. 187.6+/-91.9 pg/ml; P=0.04), decreasing to 246.1+/-160.4 after surgery (P<0.001), with no differences among surgical procedures. In controls there was an inverse correlation between VEGF-A and ghrelin (r=-0.85; P<.01), but not in obese patients. Leptin and insulin concentrations were increased in obese patients, with a significant decrease shown after weight loss with surgery. Conversely, adiponectin concentrations were lower in obese patients, with a significant increase shown after weight loss with surgery. Ghrelin was higher in controls than obese patients, decreasing after gastric bypass and biliopancreatic diversion, but not after vertical banded gastroplasty.
CONCLUSION: Serum VEGF-A levels are significantly higher in obese patients than in lean controls, decreasing after weight loss with bariatric surgery, behaving similarly to other hormones related to adipose mass like leptin and insulin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713823     DOI: 10.1210/jc.2007-1370

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

Review 1.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

2.  Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individuals.

Authors:  K S Burgdorf; A P Gjesing; N Grarup; J M Justesen; C H Sandholt; D R Witte; T Jørgensen; S Madsbad; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2011-09-28       Impact factor: 10.122

3.  The Anti-Edematous Effect of Ghrelin in Brain Hypoxia is Associated with Decreasing Expression of Vascular Endothelial Growth Factor.

Authors:  Gisou Mohaddes; Jalal Abdolalizadeh; Shirin Babri; Naghi Abedini; Fezzeh Hossienzadeh
Journal:  J Mol Neurosci       Date:  2015-03-01       Impact factor: 3.444

Review 4.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 5.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

6.  Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.

Authors:  Catherine Duggan; Liren Xiao; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-05       Impact factor: 4.254

7.  Increased skin inflammation and blood vessel density in human and experimental diabetes.

Authors:  Ana Tellechea; Antonios Kafanas; Ermelindo C Leal; Francesco Tecilazich; Sarada Kuchibhotla; Michael E Auster; Iraklis Kontoes; Jacqueline Paolino; Eugenia Carvalho; Leena Pradhan Nabzdyk; Aristidis Veves
Journal:  Int J Low Extrem Wounds       Date:  2013-02-26       Impact factor: 2.057

8.  Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

Review 9.  Ghrelin and eating disorders.

Authors:  Deniz Atalayer; Charlisa Gibson; Alexandra Konopacka; Allan Geliebter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-30       Impact factor: 5.067

Review 10.  Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease?

Authors:  H E Bays; B Laferrère; J Dixon; L Aronne; J M González-Campoy; C Apovian; B M Wolfe
Journal:  Int J Clin Pract       Date:  2009-09       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.